Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agoraphobia in phenylketonuria.

S E Waisbren1, H L Levy

  • 1Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Journal of Inherited Metabolic Disease
|January 1, 1991
PubMed
Summary

Phenylketonuria (PKU) can lead to agoraphobia in young adults. Returning to a phenylalanine-restricted diet may effectively treat these symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The natural history of classic galactosemia: lessons from the GalNet registry.

Orphanet journal of rare diseases·2019
Same author

Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics.

JIMD reports·2015
Same author

A psychosocial model of a medical problem: Maternal phenylketonuria.

The journal of primary prevention·2013
Same author

Newborn Screening for Glutaric Aciduria-II: The New England Experience.

JIMD reports·2013
Same author

Psychiatric symptoms and disorders in phenylketonuria.

Molecular genetics and metabolism·2010
Same author

A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin.

Journal of human genetics·2009

Area of Science:

  • Neuroscience
  • Metabolic Disorders
  • Psychiatry

Background:

  • Phenylketonuria (PKU) is a rare genetic disorder requiring a phenylalanine-restricted diet.
  • Adherence to the diet is often challenging for individuals with PKU, particularly in adulthood.
  • The long-term psychological impact of PKU and its management is not fully understood.

Observation:

  • Young adults with classic PKU, managed only in childhood, frequently exhibit anxiety and depression.
  • A significant percentage of these individuals also display agoraphobic behaviors, including social withdrawal and fear of leaving home.
  • Comparison groups, including those with non-PKU hyperphenylalaninemia and individuals with diabetes, showed lower rates of agoraphobia.

Findings:

  • Agoraphobia appears to be a potential complication of PKU in young adulthood.
  • Individuals who discontinued their phenylalanine-restricted diet in childhood showed higher levels of avoidant behavior.
  • Two patients who resumed the diet experienced a dramatic reduction in PKU-related symptoms, including anxiety and depression.

Implications:

  • Young adults with PKU are at an elevated risk for developing agoraphobia.
  • Reinitiating or maintaining a phenylalanine-restricted diet may serve as an effective therapeutic strategy for managing agoraphobia in PKU patients.
  • Further research is warranted to explore the neurobiological and psychosocial mechanisms linking PKU to agoraphobia.

Related Experiment Videos